Bad Blood: Secrets and Lies in a Silicon Valley Startup
by John Carreyrou
Why You'll Love This
Elizabeth Holmes convinced billionaires, patients, and a nation that her blood-testing machine worked — it never did, and Carreyrou spent years proving it.
- Great if you want: a real-life thriller about ambition, fraud, and complicity
- The experience: propulsive and infuriating — hard to put down, harder to forget
- The writing: Carreyrou writes like an investigative prosecutor: methodical, precise, devastating
- Skip if: you want psychological depth over documented facts
About This Book
At the height of Silicon Valley's obsession with disruption, Elizabeth Holmes built Theranos into a nine-billion-dollar company on a single, electrifying promise: that a few drops of blood could unlock a revolution in medical diagnostics. Patients made life-altering decisions based on her technology. Investors poured in hundreds of millions. And almost none of it was real. John Carreyrou's account of how Holmes and her inner circle sustained one of the most audacious frauds in American corporate history is as unsettling for what it reveals about ambition as for what it reveals about the systems—regulatory, journalistic, financial—that failed to stop her.
Carreyrou writes with the discipline of an investigative reporter and the instincts of a storyteller, and the combination is quietly devastating. He reconstructs the Theranos story through dozens of firsthand sources, building momentum the way a thriller does—not through sensationalism, but through accumulating, irrefutable detail. The prose is clean and controlled, which makes the revelations hit harder. Where lesser accounts would editorialize, Carreyrou simply shows you what happened and trusts you to feel the full weight of it.